Feasibility study of TS-1 after surgery with Cisplatin/Docetaxel in completely resected pathological stage II/IIIA non-small cell lung cancer (TORG0809).
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Oct 2016 Results assessing overall survival presented at the 41st European Society for Medical Oncology Congress.
- 21 Sep 2016 Status changed from active, no longer recruiting to completed.
- 04 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.